Register for the COPD Drug Development Summit
Please select the appropriate price when booking. Bookings are subject to approval.
All prices are shown in USD.
Team Discounts: Save when 3+ colleagues register together.
Register by Friday, August 21 & Save up to $260
Drug Developer Pricing*
Conference + Pre-Conference Workshop Day
(Save $180)
$3,417
On the Door: $3,597
Conference Only
(Save $180)
$2,519
On the Door: $2,699
Academic Pricing**
Conference + Pre-Conference Workshop Day
(Save $180)
$2,817
On the Door: $2,997
Conference Only
(Save $180)
$2,119
On the Door: $2,299
Service Provider Pricing***
Conference + Pre-Conference Workshop Day
(Save $260)
$4,937
On the Door: $5,197
Conference Only
(Save $180)
$3,619
On the Door: $3,799
* To be eligible for this price, the group or individuals must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services.
** To be eligible for this price, the group or individual must be full-time academic(s).
*** If you are a solution or service provider, have you considered sponsoring this event? Sponsorship includes multiple passes at a discounted rate. Inquire to learn more.
Unlock Group Discounts
Maximize value for money using special team discounts: Please note that discounts are only valid when three or more delegates from one company book and pay at the same time.
10% Off
When registering 3 attendees from one company
15% Off
When registering 4 attendees from one company
20% Off
When registering 5+ attendees from one company
Need Assistance?
If you have any questions about registration pricing, discounts or would like help in the booking process, contact us and one of the team will get back to you.
Explore the Full Event Guide
- Network with 65+ discovery, translational, clinical and regulatory experts from the likes of Johnson & Johnson, Sanofi, GSK, AstraZeneca, Merck, Connect Biopharma, Generate Biomedicines, Ethris, and many more
- Critical debates on regulatory expectations and opportunities to validate novel endpoints that de‑risk development and support faster, more confident approvals
- Expert perspectives on combining imaging, molecular, and clinical data to build a more holistic view of COPD biology and improve translational success
- Hear from 16+ respiratory specialists and C-level executives presenting novel targets and clinical trial strategies
- 3 days of essential industry collaboration including over 6 hours of specialized networking
